PortfoliosLab logo

ARCA biopharma, Inc. (ABIO)

Equity · Currency in USD · Last updated Mar 28, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in ARCA biopharma, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $0 for a total return of roughly -100.00%. All prices are adjusted for splits and dividends.

ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ABIO

ARCA biopharma, Inc.


ARCA biopharma, Inc. had a return of -12.70% year-to-date (YTD) and -12.33% in the last 12 months. Over the past 10 years, ARCA biopharma, Inc. had an annualized return of -39.25%, while the S&P 500 had an annualized return of 9.76%, indicating that ARCA biopharma, Inc. did not perform as well as the benchmark.

1 month-1.00%0.19%
6 months-2.86%7.70%
1 year-12.33%-12.45%
5 years (annualized)-26.06%8.78%
10 years (annualized)-39.25%9.76%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ARCA biopharma, Inc. Sharpe ratio is -0.40. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

Dividend History

ARCA biopharma, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the ARCA biopharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ARCA biopharma, Inc. is 100.00%, recorded on Jan 28, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-100%Nov 16, 20005333Jan 28, 2022
-87.35%Sep 29, 1997385Apr 9, 1999190Jan 7, 2000575
-14.06%Aug 12, 19976Aug 19, 199714Sep 9, 199720
-7.58%May 26, 20001May 26, 20001May 30, 20002
-4.74%Apr 17, 20001Apr 17, 20001Apr 18, 20002
-2.74%Sep 15, 19972Sep 16, 19972Sep 18, 19974
-0.66%Sep 22, 19971Sep 22, 19971Sep 23, 19972

Volatility Chart

Current ARCA biopharma, Inc. volatility is 29.04%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)